Current Research into Cures for Type-1 Diabetes News and updates on potential cures for type-1 diabetes, that are in human or clinical trials. Monday, October 29, Golimumab Update Golimumab sold as Simponi is an immune system modulator, which has been approved in the United States and many other countries for treatment of several autoimmune diseases, so testing it on type-1 diabetes makes a lot of sense. Simponi has already been approved to treat rheumatoid arthritis, psoriatic arthritis, ulcerative colitis, and ankylosing spondylitis. Golimumab is a monoclonal antibody, which is an artificially created antibody which targets one very specific molecule in the body.
Diabetes is a chronic, metabolic disease characterized by elevated levels of blood glucose or blood sugarwhich leads over time to serious damage to the heart, blood vessels, eyes, kidneys, and nerves.
The most common is type 2 diabetes, usually in adults, which occurs when the body becomes resistant to insulin or doesn't make enough insulin.
In the past three decades the prevalence of type 2 diabetes has risen dramatically in countries of all income levels. Type 1 diabetes, once known as juvenile diabetes or insulin-dependent diabetes, is a chronic condition in which the pancreas produces little or no insulin by itself.
For people living with diabetes, access to affordable treatment, including insulin, is critical to their survival. There is a globally agreed target to halt the rise in diabetes and obesity by About the diabetes programme The mission of the WHO Diabetes Programme is to prevent type 2 diabetes and to minimize complications and maximize quality of life for all people with diabetes.
Our core functions are to set norms and standards, promote surveillance, encourage prevention, raise awareness and strengthen prevention and control.More information on the Program and the research it supports is available on the Type 1 Diabetes Research Special Statutory Funding Program website.
In addition, NIDDK has congressional authorization for the National Diabetes Information Clearinghouse. Golimumab (sold as Simponi) is an immune system modulator, which has been approved in the United States and many other countries for treatment of several autoimmune diseases, so testing it on type-1 diabetes makes a lot of sense.
Welcome to Diabetologia, the official journal of the EASD.
We publish high-quality, cutting edge articles on all aspects of diabetes, from basic science through translational work to clinical research. What's New and Beneficial About Pears.
For nutritional reasons, we're often advised to consume the skins of fruits. However, it's less often that research provides strong evidence in support of this advice.
Marijuana is currently legal for medical use in 28 American states and the District of Columbia. There are increasing evidence to support the claims that the Cannabis plant offers many potential medicinal properties for a wide number of diseases and disorders.
Global Prevalence of Diabetes Estimates for the year and projections for SARAH WILD, MB BCHIR, PHD 1 GOJKA ROGLIC,MD 2 ANDERS GREEN, MD, PHD, DR MED SCI 3 RICHARD SICREE, MBBS, MPH 4 HILARY KING MD DSC 2 OBJECTIVE— The goal of this study was to estimate the prevalence of diabetes and the number of people of all ages with diabetes for years and